Fact CheckerSign in

NCT06628102Recruiting

Improving Detection of Early Lung Cancer in a Diverse Population (IDEAL) Study

Improving Detection of Early Lung Cancer in a Diverse Population

Source: ClinicalTrials.gov · Last updated 4 Oct 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The goal of this trial is to (a) identify people at high risk of lung cancer who would benefit from LDCT screening but are currently ineligible based on current lung cancer screening criteria (b) provide the framework to manage patients with Incidental Pulmonary Nodules (IPNs) with appropriate follow-up based on accurate interpretation of the Chest CT scan that is already available and (c) develop a simple, point-of-care, minimally invasive test, focusing on the breath and circulating blood proteins, to detect lung cancer, and develop a method to differentiate between cancerous and non-cancerous nodules using a single. Participants will be asked to answer a questionnaire regarding their age, race/ethnicity, smoking history, and residential history if they have ever been told they have chronic obstructive pulmonary disease (COPD), high blood pressure, education level, medications and height and weight. Participants will then be asked to give a breath sample via the breath collection device. All this information will be collected before the breath collection. After that, participants will give 1-2 tablespoons of blood. CT scans with IPN(s) will be reviewed and run through a computer detection software to identify nodules, followed up as per current clinical guidelines.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
3600 (estimated)
First submitted
10 Oct 2023
Start date
4 Aug 2023
Primary completion date
31 Dec 2028
Lead sponsor
British Columbia Cancer Agency
Diseases
Lung cancer
NCT number
NCT06628102

What you commit to

  • Study type: Interventional
  • Planned participants: 3600
  • From 4 Aug 2023 to the primary completion date, 31 Dec 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • You have been diagnosed with a respiratory infection in the last 3 months

Other

  • Too sick to provide a breath sample
  • you have smoked in the last 24 hours
  • You are pregnant
  • Unwilling to consent to the study

Who the study is looking for

  • Age 50-80
  • Able to consent
  • Chest CT positive for nodule equal to or greater than 6mm
  • No additional other cancer- (outside of lung cancer for group 1)
  • Must be able to abstain from smoking tobacco for 24 hours prior to the breath test.

Age in the registry: 50 years to 80 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
BC Cancer Research, part of the Provincial Health Authority
Coordinator of this site? Confirm its status
VancouverCanadaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.